Efficacy Comparison of Warfarin Versus Rivaroxaban CVT

Comparing Treatment Outcomes in CVT Patients Who Treated With Warfarin and Rivaroxaban in Isfahan, Iran

With regard to Cerebral Venous Thrombosis (CVT) importance as a life threatening disease, specific care is necessary, Known anti-coagulants have limitations.Vitamin K antagonists such as Warfarin, require laboratory monitoring and exact administration starting and maintenance dose. although Rivaroxaban(selective and direct Xa factor antagonist ) has no monitoring and no drug interaction. This study aim to focus on efficacy of Warfarin versus Rivaroxaban.

IInclusion Criteria:

• Patients of both gender
• Age 18 years and higher
• proven CVT on neuro imaging ( MRI-MRV)

Exclusion Criteria:

• Patients suffering from renal failure(GFR<30) Patients
• Patients with contraindications for oral anticoagulation
• Patient who having pregnancy
• Uncooperative patient for completing the course of treatment